Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/21/2012US8247404 Derivatives of 2-oxoalkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same
08/21/2012US8247403 Benzoxazepine derivatives and use thereof
08/21/2012US8247402 Crystal form of pyrrolidylthiocarbapenem derivative
08/21/2012US8247401 P2X3 receptor antagonists for treatment of pain
08/21/2012US8247400 Cephem compounds useful for the treatment of bacterial infections
08/21/2012US8247399 Photoactive metal nitrosyls for blood pressure regulation and cancer therapy
08/21/2012US8247398 free of external ions; e.g. zinc bisarginate; copper-related conditions such as Wilson's disease, inflammatory disease, and/or a fibrotic disease; inducing metallothionein
08/21/2012US8247397 Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use
08/21/2012US8247396 Polyquinoline derivatives and therapeutic use thereof
08/21/2012US8247395 Topical skin care composition
08/21/2012US8247394 Methods of treating urethritis and related infections using fusidic acid
08/21/2012US8247393 Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
08/21/2012US8247391 Macromolecules, lectins, dextrans, and/or concanavalin A moieties bind reversibly attached to crosslinked particles; sol-gel transformation; drug delivery
08/21/2012US8247390 Modified hydrophilic polymers containing hydrophobic groups
08/21/2012US8247389 Treatment of scleroderma
08/21/2012US8247387 Methods and compositions for the treatment of eye disorders with increased intraocular pressure
08/21/2012US8247384 Methods and compositions for wound healing
08/21/2012US8247382 Method for increasing oxytocin release in the epidermis
08/21/2012US8247381 Branched water-soluble polymers and their conjugates
08/21/2012US8247379 Tumor associated amino acids and uses therefor
08/21/2012US8247377 Non-steroidal glucocorticoid inhibitors and their use in treating inflammation, allergy and auto-immune conditions
08/21/2012US8247231 Methods and compositions for producing antigenic responses
08/21/2012US8247008 Digestive/laxative compositions
08/21/2012US8246997 Compositions comprising solid particles encapsulated in a cross-linked silicone matrix, and methods of making the same
08/21/2012US8246996 comprising immediate release, sustained release and delayed release dosage forms, with each dosage forms having a different release profile, wherein each reaches a maximum concentration at different times
08/21/2012US8246989 Dosage forms of bisphosphonates
08/21/2012US8246986 Drug coating providing high drug loading
08/21/2012US8246982 Pressure-sensitive adhesives based on ethylene-vinyl acetate copolymers and adhesive resins, for medical application purposes
08/21/2012US8246980 Transdermal delivery system
08/21/2012US8246979 Multilayer drug delivery system; protective foils, microreservoirs; silicone pressure sensitive adhesive; Parkinson's disease
08/21/2012US8246977 patches has pressure-sensitive adhesive matrix containing a polyisobutylene, free of permeation enhancer, for drug deliverying sufentanil through the skin to provide an analgesic effect, pain management; sustained release, side effect reduction, consistent concentration in blood
08/21/2012US8246975 Drug, drug guidance system, magnetic detection system, and drug design method
08/21/2012US8246974 Medical devices and methods for producing the same
08/21/2012US8246972 comprising sphingoids used as cosmetic for topical application with animals having fur covered skins for maintaining and/or repairing the keratoseborrheaic condition of the skin and/or fur; skin disorders
08/21/2012US8246971 Compositions containing aromatic aldehydes and their use in treatment
08/21/2012US8246969 Compositions containing aromatic aldehydes and their use in treatments
08/21/2012US8246968 Cancer cell targeting using nanoparticles
08/21/2012US8246949 Methods and devices for sustained in-vivo release of an active agent
08/21/2012US8246943 Prebiotic composition
08/21/2012US8246930 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
08/21/2012CA2698332C Pyrazole derivatives as soluble guanylate cyclase activators
08/21/2012CA2689429C Bicycloaniline derivatives
08/21/2012CA2674379C Method of treating hyperesthesia, paresthesia, dolor, and pruritus caused by insect stings or noxious weeds or plants using avermectin compound
08/21/2012CA2673510C Maleic acid monosalt of antiviral agent and pharmaceutical composition containing the same
08/21/2012CA2643732C Oxysterol compounds and the hedgehog pathway
08/21/2012CA2634469C Tiglien-3-one derivatives
08/21/2012CA2633413C Antibodies against tumor-associated antigenic target (tat) polypeptides
08/21/2012CA2628806C Injectable liquid paracetamol formulation
08/21/2012CA2616196C A pyridin quinolin substituted pyrrolo [1,2-b] pyrazole monohydrate as tgf-beta inhibitor
08/21/2012CA2604253C Dietary supplement, and methods of use
08/21/2012CA2595211C Anti-penicillin resistant pneumococci agent and novel 16-membered macrolide derivative
08/21/2012CA2580367C Formulations of suberoylanilide hydroxamic acid and methods for producing same
08/21/2012CA2566215C Cyclohexyl-1,4-diamines substituted by acid derivatives
08/21/2012CA2562190C Novel antiviral pharmaceutical composition
08/21/2012CA2555457C A novel therapeutic agent for amyotrophic lateral sclerosis (als) or diseases caused by als
08/21/2012CA2552319C Hcv ns-3 serine protease inhibitors
08/21/2012CA2545427C Selective kinase inhibitors
08/21/2012CA2543793C Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pain
08/21/2012CA2542442C Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor
08/21/2012CA2540730C Alfavbeta3 and alfavbeta6 integrin antagonists as antifibrotic agents
08/21/2012CA2540370C Novel thioxylose compounds, preparation method thereof, pharmaceutical compositions containing same and use thereof in therapeutics
08/21/2012CA2535004C Topical veterinary compositions and methods for the treatment and prevention of infection
08/21/2012CA2530075C Amphiphilic pyridinium compounds, method of making and use thereof
08/21/2012CA2527805C Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs
08/21/2012CA2527024C Compositions and methods for inhibiting an isoform of human manganese superoxide dismutase
08/21/2012CA2521967C Nutritional or therapeutic composition containing the compound oleuropeine or one of the derivatives thereof
08/21/2012CA2520892C Chromenoneindoles
08/21/2012CA2516370C A process of preparing imatinib and imatinib prepared thereby
08/21/2012CA2514090C Use of glutathione synthesis stimulating compounds in reducing insulin resistance
08/21/2012CA2511021C Substituted benzodioxepines
08/21/2012CA2509086C Substituted arylcyclopropylacetamides as glucokinase activators
08/21/2012CA2500498C Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof
08/21/2012CA2497351C Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same
08/21/2012CA2495830C The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
08/21/2012CA2479877C Substituted tetracycline compounds
08/21/2012CA2473886C Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
08/21/2012CA2472920C Methods of reducing angiogenesis
08/21/2012CA2469076C Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
08/21/2012CA2459794C Vascular occlusion solid-phase agent with immobilised platelet binding agent
08/21/2012CA2452769C Antiviral agent
08/21/2012CA2450121C Antimicrobial and radioprotective compounds
08/21/2012CA2449284C Alpha-fetoprotein peptides and uses thereof
08/21/2012CA2434388C Activated charcoal based composition and method for reducing hangover symptoms associated with the consumption of alcohol containing beverages
08/21/2012CA2412759C Injectable solution of an lhrh antagonist
08/21/2012CA2408032C Preparation for the prevention and/or treatment of vascular disorders
08/21/2012CA2398264C Use of desloratadine for treating allergic and inflammatory conditions
08/21/2012CA2371723C Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
08/21/2012CA2337807C Novel acyl pseudodipeptides, preparation method and pharmaceutical compositions containing same
08/21/2012CA2288143C Activated protein c formulations
08/21/2012CA2251576C Glucagon-like peptide-2 analogs
08/21/2012CA2233924C Novel stable liquid paracetamol compositions, and method for preparing same
08/21/2012CA2210190C Method for modulating processes mediated by farnesoid activated receptors
08/16/2012WO2012109673A1 Methods of treating macular edema using antiedema therapeutics
08/16/2012WO2012109646A1 Treatment of hcv in hiv infection patients
08/16/2012WO2012109605A2 Forms of rifaximin and uses thereof
08/16/2012WO2012109573A1 Substituted thiazoles for use as antiviral agents
08/16/2012WO2012109544A1 Novel 1-(1-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)urea derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators
08/16/2012WO2012109527A2 Class of hdac inhibitors expands the renal progenitor cells population and improves the rate of recovery from acute kidney injury
08/16/2012WO2012109510A1 Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds
08/16/2012WO2012109473A2 Detection of endotoxins
1 ... 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 ... 7860